• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Mark J. Millan, Benjamin Di Cara, +6 authors Alain P Gobert
  • Biology, Medicine
  • Journal of neurochemistry
  • 2007 (First Publication: 1 February 2007)
  • Though dopaminergic mechanisms modulate cholinergic transmission and cognitive function, the significance of specific receptor subtypes remains uncertain. Here, we examined the roles of dopamine D(3)Continue Reading
  • Benjamin Di Cara, Roberto Maggio, +19 authors Mark J. Millan
  • Medicine, Biology
  • The Journal of neuroscience : the official…
  • 2011 (First Publication: 23 November 2011)
  • "Ecstasy" [3,4-methylenedioxymetamphetamine (MDMA)] is of considerable interest in light of its prosocial properties and risks associated with widespread recreational use. Recently, it was found toContinue Reading
  • Mark J. Millan, Alain P Gobert, +10 authors Anne Dekeyne
  • Chemistry, Medicine
  • The Journal of pharmacology and experimental…
  • 2004 (First Publication: 1 October 2004)
  • These studies examined the influence of the selective 5-hydroxytryptamine (serotonin) (5-HT)(1A) receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] upon cholinergicContinue Reading
  • Benjamin Di Cara, Fany Panayi, +4 authors Mark J. Millan
  • Psychology, Medicine
  • The international journal of…
  • 2007 (First Publication: 1 June 2007)
  • Although dopaminergic mechanisms are known to modulate cognitive function and cholinergic transmission, their pharmacological characterization remains incomplete. Herein, the role of D1 sites wasContinue Reading
  • Anne Dekeyne, Mauricette Brocco, +15 authors Mark J. Millan
  • Chemistry, Medicine
  • The Journal of pharmacology and experimental…
  • 2012 (First Publication: 1 March 2012)
  • The present studies characterized the functional profile of N-[4-methoxy-3-(4-methylpiperazin-1-yl)phenyl]-1,2-dihydro-3-H-benzo[e]indole-3-carboxamide) (S32212), a combined serotonin (5-HT)(2C)Continue Reading
  • Mark J. Millan, Alain P Gobert, +5 authors Benjamin Di Cara
  • Psychology, Medicine
  • The international journal of…
  • 2008 (First Publication: 1 December 2008)
  • Melanin-concentrating hormone (MCH)1 receptors are widely expressed in limbic structures and cortex. Their inactivation is associated with anxiolytic and antidepressive properties but littleContinue Reading
  • Anthony Gobert, Benjamin Di Cara, Laetitia Cistarelli, Mark J. Millan
  • Chemistry, Medicine
  • The Journal of pharmacology and experimental…
  • 2003 (First Publication: 1 April 2003)
  • In a dialysis procedure not requiring perfusate addition of acetylcholinesterase inhibitors to "boost" basal levels of acetylcholine (ACh), the influence of the antiparkinson agent piribedil uponContinue Reading
  • Mark J. Millan, Benjamin Di Cara, +10 authors Mauricette Brocco
  • Chemistry, Medicine
  • The Journal of pharmacology and experimental…
  • 2004 (First Publication: 1 June 2004)
  • These studies evaluated the potential antiparkinsonian properties of the novel dopamine D(3)/D(2) receptor agonist S32504 [(+)-trans-3,4,4a,5,6,Continue Reading
  • Mark J. Millan, Per Svenningsson, +15 authors Alain P Gobert
  • Medicine, Chemistry
  • The Journal of pharmacology and experimental…
  • 2008 (First Publication: 1 February 2008)
  • The novel benzopyranopyrrolidine, S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], is a preferential antagonist of cloned humanContinue Reading